Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $38.60 $44.37 Friday, 10th May 2024 XENE stock ended at $40.54. This is 4.59% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 10.26% from a day low at $38.60 to a day high of $42.56.
90 days $38.60 $50.99
52 weeks $27.99 $50.99

Historical Xenon Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Nov 09, 2023 $33.42 $34.25 $29.67 $30.00 2 089 472
Nov 08, 2023 $31.80 $32.20 $31.11 $32.15 404 978
Nov 07, 2023 $32.87 $33.27 $31.76 $31.79 780 830
Nov 06, 2023 $32.88 $32.90 $32.10 $32.86 406 903
Nov 03, 2023 $33.37 $33.88 $32.77 $32.88 450 691
Nov 02, 2023 $31.55 $33.12 $31.55 $33.07 707 274
Nov 01, 2023 $31.17 $31.48 $30.28 $31.22 436 920
Oct 31, 2023 $31.32 $31.78 $30.07 $31.00 643 845
Oct 30, 2023 $31.38 $31.95 $30.65 $31.50 367 853
Oct 27, 2023 $31.04 $31.92 $30.48 $30.87 657 603
Oct 26, 2023 $33.04 $33.09 $30.91 $31.14 560 122
Oct 25, 2023 $32.81 $34.23 $32.35 $32.95 243 785
Oct 24, 2023 $32.89 $33.46 $32.31 $33.15 338 682
Oct 23, 2023 $33.24 $33.24 $32.36 $32.70 360 440
Oct 20, 2023 $34.95 $35.17 $32.96 $33.24 441 558
Oct 19, 2023 $35.07 $35.32 $34.50 $34.95 527 493
Oct 18, 2023 $35.03 $35.15 $34.50 $34.92 212 366
Oct 17, 2023 $34.95 $35.71 $34.72 $35.29 222 557
Oct 16, 2023 $35.28 $35.45 $34.61 $34.98 487 863
Oct 13, 2023 $34.72 $35.44 $33.43 $35.14 191 076
Oct 12, 2023 $35.27 $35.54 $34.48 $34.72 217 282
Oct 11, 2023 $36.97 $36.97 $34.94 $35.38 332 276
Oct 10, 2023 $35.60 $36.78 $35.52 $36.69 566 562
Oct 09, 2023 $35.39 $35.90 $35.19 $35.49 230 027
Oct 06, 2023 $35.19 $35.85 $32.65 $35.61 253 326
Click to get the best stock tips daily for free!

About Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals. Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopathy; and XEN1101, A Kv7 potassium channel opener, which is in Phase II clinical trial for the treatment o... XENE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT